European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment

Alexander J. Stratigos*, Claus Garbe, Clio Dessinioti, Celeste Lebbe, Veronique Bataille, Lars Bastholt, Brigitte Dreno, Maria Concetta Fargnoli, Ana M. Forsea, Cecille Frenard, Catherine A. Harwood, Axel Hauschild, Christoph Hoeller, Lidija Kandolf-Sekulovic, Roland Kaufmann, Nicole W. J. Kelleners-Smeets, Josep Malvehy, Veronique del Marmol, Mark R. Middleton, David Moreno-RamirezGiovanni Pellecani, Ketty Peris, Philippe Saiag, Marieke H. J. van den Beuken-van Everdingen, Ricardo Vieira, Iris Zalaudek, Alexander M. M. Eggermont, Jean-Jacques Grob, European Dermatology Forum (EDF), European Association of Dermato-Oncology (EADO), European Organization for Research and Treatment of Cancer (EORTC)

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Web of Science)
Original languageEnglish
Pages (from-to)83-102
Number of pages20
JournalEuropean Journal of Cancer
Volume128
DOIs
Publication statusPublished - Mar 2020

Keywords

  • Cutaneous squamous cell carcinoma
  • Locally advanced
  • Metastatic
  • Treatment
  • Surgical excision
  • Radiotherapy
  • Anti-PD-1 antibody
  • Cemiplimab
  • Chemotherapy
  • EGFR inhibitors
  • Follow-up
  • ORGAN TRANSPLANT RECIPIENTS
  • METASTATIC CUTANEOUS HEAD
  • ELECTIVE NECK DISSECTION
  • GROWTH-FACTOR RECEPTOR
  • IN-TRANSIT METASTASIS
  • CERVICAL LYMPH-NODES
  • PHASE-II
  • ADJUVANT RADIOTHERAPY
  • INTERFERON-ALPHA
  • INTRALESIONAL METHOTREXATE

Cite this